The 5q- syndrome

The 5q- syndrome

Bibliographic Details
Main Authors:	Elvira Deolinda Rodrigues Pereira Velloso, Vera Lucia Aldred
Format:	Article
Language:	English
Published:	Instituto Israelita de Ensino e Pesquisa Albert Einstein 2007-06-01
Series:	Einstein (São Paulo)
Online Access:	http://www.einstein.br/revista/arquivos/PDF/542-182-183.learning-the.5q.5.2.1.pdf

Similar Items

Scientific comment on tumor suppressor p53 protein expression: prognostic significance in patients with low-risk myelodysplastic syndrome
by: Elvira Deolinda Rodrigues Pereira Velloso
Published: (2014-06-01)

Van den Berghe's 5q- syndrome and myelodysplastic syndrome with isolated del(5q)
by: Diego Silva Lima, et al.
Published: (2015-12-01)

Detection of cytogenetic abnormalities in mature B-cell neoplasms: the value of cultures with different mitogens
by: Roberta Maria da Silva Oliveira, et al.
Published: (2014-10-01)

5q deletion myelodysplastic syndrome
by: Preethi S Chari, et al.
Published: (2017-01-01)

RECENT ADVANCES IN THE 5Q- SYNDROME
by: Andrea Pellagatti, et al.
Published: (2015-05-01)

Molecular analysis of the 5q- syndrome
by: Fidler, Carrie
Published: (1997)

Parvovirus B19 infection
by: Elvira Deolinda Rodrigues Pereira Velloso, et al.
Published: (2008-03-01)

A Rare Interstitial Duplication of 8q22.1–8q24.3 Associated with Syndromic Bilateral Cleft Lip/Palate
by: Regina Ferreira Rezek, et al.
Published: (2014-01-01)

An Investigation into the Molecular Pathogenesis of the Myelodysplastic Syndromes (MDS), in Particular the 5q- Syndrome
by: Watkins, Fiona
Published: (2010)

Molecular genetic techniques for gains and losses of genomic material in a case of acute myeloid leukemia
by: Mauren Fernanda Moller dos Santos, et al.

Fatores de crescimento hemopoéticos nas síndromes mielodisplásicas Hematopoietic growth factors in myelodysplastic syndromes
by: Elvira R. P. Velloso
Published: (2006-09-01)

Chromosomal engineering to produce a model of human 5q-syndrome
by: Holmes, L. R.
Published: (2006)

Agentes imunossupressores, talidomida e ácido valpróico nas síndromes mielodisplásicas Immunosuppressive agents, thalidomide and valproate acid in myelodysplastic syndromes
by: Elvira R. P. Velloso
Published: (2006-09-01)

Differential Expression of MicroRNAs in CD34+ Cells of 5q- Syndrome
by: Vasikova Alzbeta, et al.
Published: (2011-01-01)

Lenalidomide-related malar rash-like lesion in patient with 5q-syndrome
by: Gokhan Sargin, et al.
Published: (2019-01-01)

Analysis of expressed sequence tags mapping to the critical region of the 5q syndrome
by: Strickson, Amanda J.
Published: (2002)

AGE, PERFORMANCE STATUS AND LENALIDOMIDE THERAPY INDEPENDENTLY INFLUENCE THE OUTCOME OF PATIENTS WITH MYELODYSPLASTIC SYNDROME WITH ISOLATED DEL(5Q) FROM SOUTH AMERICA
by: R.S. Azevedo, et al.
Published: (2020-11-01)

Aspergillary bronchopneumonia: an unusual cause of atelectasis and asphyxia in a leukemic patient
by: Elvira Deolinda Rodrigues Pereira Velloso, et al.

Identification of Lenalidomide Sensitivity and Resistance Mechanisms in Non-Del(5q) Myelodysplastic Syndromes
by: Leylah M. Drusbosky, et al.
Published: (2020-05-01)

Routes of Clonal Evolution into Complex Karyotypes in Myelodysplastic Syndrome Patients with 5q Deletion
by: Simone Feurstein, et al.
Published: (2018-10-01)

Unravelling haematopoietic stem cell dysfunction in isolated Del(5q) myelodysplastic syndromes
by: Stenson, Laura
Published: (2015)

The role of haploinsufficiency of RPS14 and p53 activation in the molecular pathogenesis of the 5q- syndrome
by: Jacqueline Boultwood
Published: (2011-06-01)

Terminal 4q deletion syndrome
by: C M Kuldeep, et al.
Published: (2012-01-01)

The long Q— Т syndrome with syncope
by: D. I. Sadykova, et al.
Published: (2016-03-01)

Mosaic 15q duplication syndrome (tetrasomy 15q11.1-q13.2) in a child with behavior disorders: case report
by: Maurício A. Rodrigues, et al.

A case of myelodysplastic syndrome with t(10;18)(q26;q21)
by: Yusuke Ohba, et al.
Published: (2019-10-01)

Corticosteroid-resistant Sweet syndrome in the setting of acute myeloid leukemia with monosomy 7 and 5q deletion
by: Fritzlaine C. Roche, MS, et al.
Published: (2020-12-01)

Long-term hematological response in 5q- syndrome after lenalidomide suspension and further improvement by deferasirox.
by: Pasquale Niscola
Published: (2014-08-01)

Webbokning i TeleQ 5
by: Middendorff, Rasmus
Published: (2012)

De aenigmate 7Q 5
by: Jerzy Chmiel
Published: (1995-09-01)

A case of 15q11‐q13 duplication syndrome and literature review
by: Zhuo Fu, et al.
Published: (2021-08-01)

Deletion 22q13.3 syndrome
by: Phelan Mary C
Published: (2008-05-01)

Chromosome 15q24 microdeletion syndrome
by: Magoulas Pilar L, et al.
Published: (2012-01-01)

Chromosome 11q13 deletion syndrome
by: Yu-Seon Kim, et al.
Published: (2016-11-01)

Four novel Loci (19q13, 6q24, 12q24, and 5q14) influence the microcirculation in vivo.
by: M Kamran Ikram, et al.
Published: (2010-10-01)

Correction: Four Novel Loci (19q13, 6q24, 12q24, and 5q14) Influence the Microcirculation.
by: M. Kamran Ikram, et al.
Published: (2010-11-01)

C1q/TNF-Related Protein5 (CTRP5) as a Biomarker to Predict Metabolic Syndrome and Each of Its Components
by: Feiyu Jiang, et al.
Published: (2018-01-01)

Analysis of Intratumoral Heterogeneity in Myelodysplastic Syndromes with Isolated del(5q) Using a Single Cell Approach
by: Pamela Acha, et al.
Published: (2021-02-01)

Economic evaluation of lenalidomide (Revlimid®) for the treatment of mielodysplastic syndrome with 5q deletion at low/intermediate-1 risk
by: Christian Ramos, et al.
Published: (2017-06-01)

Complete Remission of del(5q) Myelodysplastic Syndrome after 7 Days of Lenalidomide Therapy Gives an Alert!
by: Hassan A. Al-Jafar, et al.
Published: (2012-10-01)